Nurse Practitioner, Adult Health · New York, NY
NPI
1891234191
Since 2017
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
161 Fort Washington Ave
New York, NY, 10032
Phone (212) 305-3997
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,867
51 services
Medicare patients, 2024
15
Average age 75
Drug cost, 2024
$6.2M
890 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kimberly N Nojima Chan was code 99215 (office e&m - established), 26 times for 14 patients. In total Kimberly N Nojima Chan billed 51 services in 3 codes, and Medicare paid $3,867.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 26 | 14 | $133.81 | $3,479 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 24 | 13 | $12.14 | $291 |
By year: 2022 $1,955 for 19 services; 2023 $2,162 for 18 services; 2024 $3,867 for 51 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kimberly N Nojima Chan prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 206 prescriptions and refills. In total Kimberly N Nojima Chan wrote 890 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 206 | 219 | 30 | $3.8M |
| Alecensa Alectinib Hcl | 48 | 48 | Under 11 | $674K |
| Ondansetron Hcl Generic | 41 | 41 | 17 | $435 |
| Mirtazapine Generic | 41 | 109 | 17 | $1,044 |
| Oxycodone Hcl Generic | 39 | 39 | 22 | $368 |
| Dexamethasone Generic | 33 | 35 | 26 | $496 |
| Xarelto Rivaroxaban | 28 | 36 | Under 11 | $19K |
| Prochlorperazine Maleate Generic | 25 | 25 | 16 | $243 |
| Eliquis Apixaban | 25 | 41 | Under 11 | $22K |
| Lorazepam Generic | 25 | 25 | 11 | $39.52 |
| Gilotrif Afatinib Dimaleate | 18 | 18 | Under 11 | $200K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 18 | 18 | Under 11 | $914 |
| Lorbrena Lorlatinib | 16 | 16 | Under 11 | $326K |
| Xalkori Crizotinib | 15 | 15 | Under 11 | $238K |
| Enoxaparin Sodium Generic | 13 | 13 | Under 11 | $1,458 |
Brand drugs: 461 claims; generic drugs: 429 claims; opioid claims: 56.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kimberly N Nojima Chan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.